FDA 483 - Beckman Coulter, Inc. - December 11, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Beckman Coulter, Inc. in Chaska, MN, revealed significant deficiencies in their quality management system. The firm's risk analysis procedures were found to be inadequate, with issues in defining qualitative risk levels and implementing post-launch risk assessments. Additionally, the inspection cited failures in establishing and implementing corrective and preventive actions, as well as insufficient control over nonconforming products and inadequately established design change procedures.
ID · 19faf556-d51c-4212-a756-6587a52fa301